Sera Prognostics (SERA) Long-Term Investments (2021 - 2026)
Sera Prognostics (SERA) posted Long-Term Investments of $39.4 million for Q1 2026, down 30.42% on a QoQ basis from $56.6 million in Q4 2025, and down 42.11% year-over-year from $68.0 million in Q1 2025.
Sera Prognostics (SERA) Long-Term Investments (2021 - 2026) Analysis & Trends
Sera Prognostics' Long-Term Investments history runs 6 years deep, the most recent figure standing at $39.4 million for Q1 2026.
- Quarterly Long-Term Investments fell 42.11% year-over-year to $39.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.4 million (down 42.11% YoY) and the FY2025 annual result came in at $56.6 million, up 157.49% from the prior year.
- Long-Term Investments was $39.4 million for Q1 2026 at Sera Prognostics, down from $56.6 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $68.4 million in Q2 2025 and bottomed at $13.7 million in Q2 2022.
- A 5-year average of $35.7 million and a median of $30.0 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2025 — Long-Term Investments surged 157.49% — and 2026, when it slumped 42.11%.
- Sera Prognostics' Long-Term Investments stood at $21.3 million in 2022, then surged by 44.6% to $30.8 million in 2023, then fell by 28.75% to $22.0 million in 2024, then soared by 157.49% to $56.6 million in 2025, then tumbled by 30.42% to $39.4 million in 2026.
- Business Quant data shows SERA's Long-Term Investments at $39.4 million in Q1 2026, $56.6 million in Q4 2025, and $59.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | 121.00 Mn |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 166.25 Mn |
| 10 | Sera Prognostics | 103.03 Mn | 103.03 Mn | -28,000.00 | 39.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.37 Mn |
| Dec 31, 2025 | 56.58 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Jun 30, 2025 | 68.35 Mn |
| Mar 31, 2025 | 68.00 Mn |
| Dec 31, 2024 | 21.97 Mn |
| Sep 30, 2024 | 24.59 Mn |
| Jun 30, 2024 | 30.01 Mn |
| Mar 31, 2024 | 32.39 Mn |
| Dec 31, 2023 | 30.84 Mn |
| Sep 30, 2023 | 38.92 Mn |
| Jun 30, 2023 | 28.31 Mn |
| Mar 31, 2023 | 28.92 Mn |
| Dec 31, 2022 | 21.33 Mn |
| Sep 30, 2022 | 22.38 Mn |
| Jun 30, 2022 | 13.68 Mn |
| Mar 31, 2022 | 22.34 Mn |
| Dec 31, 2021 | 34.85 Mn |
| Sep 30, 2021 | 30.00 Mn |